Dashboard
Manage Tickers

AKBA


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

akebia-therapeutics-presents-data-at-asn-kidney-week-says-vadadustat-shows-statistically-significant-reduction-in-death-and-hospitalization-in-dialysis-patients
Akebia Therapeutics Presents Data At ASN K...
11/06/2025 23:35:11

Akebia Therapeutics®, Inc. (NASDAQ:AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted b...

top-3-health-care-stocks-which-could-rescue-your-portfolio-in-november
Top 3 Health Care Stocks Which Could Rescu...
11/04/2025 11:24:48

hc-wainwright--co-maintains-buy-on-akebia-therapeutics-lowers-price-target-to-6
HC Wainwright & Co. Maintains Buy on Akebi...
10/30/2025 11:51:16

HC Wainwright & Co. analyst Matthew Caufield maintains Akebia Therapeutics (NASDAQ:AKBA) with a Buy and lowers the price...

fda-pushback-prompts-akebia-to-drop-broad-label-pursuit-for-kidney-disease-drug
FDA Pushback Prompts Akebia To Drop Broad ...
10/29/2025 18:13:46

Akebia shares decline after the company ends plans for its VALOR trial, citing FDA feedback and high costs tied to expanding Va...

btig-maintains-buy-on-akebia-therapeutics-lowers-price-target-to-5
BTIG Maintains Buy on Akebia Therapeutics,...
10/29/2025 17:49:36

BTIG analyst Julian Harrison maintains Akebia Therapeutics (NASDAQ:AKBA) with a Buy and lowers the price target from $10 to $5.

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
10/29/2025 17:06:03

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
10/29/2025 12:06:08

mondelez-international-stride-varonis-systems-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session
Mondelez International, Stride, Varonis Sy...
10/29/2025 12:05:16

why-teradyne-shares-are-trading-higher-by-more-than-20-here-are-20-stocks-moving-premarket
Why Teradyne Shares Are Trading Higher By ...
10/29/2025 09:05:41

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
10/28/2025 21:13:44

akebia-therapeutics-says-fda-has-not-come-to-alignment-on-path-forward-for-design-of-valor-clinical-trial-for-use-of-vafseo-in-non-dialysis-patients
Akebia Therapeutics Says FDA Has Not Come ...
10/28/2025 20:34:48

akebia-therapeutics-and-innovative-renal-care-announce--vafseo-availability-in-irc-dialysis-clinics
Akebia Therapeutics And Innovative Renal C...
08/21/2025 12:10:09

akebia-therapeutics-q2-sales-62472m-beat-47637m-estimate
Akebia Therapeutics Q2 Sales $62.472M Beat...
08/07/2025 11:03:41

Akebia Therapeutics (NASDAQ:AKBA) reported quarterly sales of $62.472 million which beat the analyst consensus estimate of $47....

Core News & Articles
Earnings Scheduled For August 7, 2025
08/07/2025 08:33:15

earnings-preview-for-akebia-therapeutics
Earnings Preview For Akebia Therapeutics
08/06/2025 19:03:28

akebia-therapeutics-initiates-post-marketing-study-to-identify-additional-potential-benefits-of-vafseo
Akebia Therapeutics Initiates Post-Marketi...
08/04/2025 12:09:08

Akebia Therapeutics®, Inc. (NASDAQ:AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted b...

Core News & Articles
9 Health Care Stocks Whale Activity In Tod...
06/04/2025 17:35:27

akebia-therapeutics-announces-publication-in-jasn-of-us-and-non-us-subgroup-analyses-from-vadadustat-global-phase-3-trials-showing-comparable-safety-and-efficacy-in-dialysis-dependent-ckd-patients-and-highlighting-elevated-mace-risk-in-us-nondialysis-dependent-ckd-patients
Akebia Therapeutics Announces Publication ...
06/04/2025 12:19:56

Akebia Therapeutics®, Inc. (NASDAQ:AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted b...

hc-wainwright--co-assumes-akebia-therapeutics-at-buy-announces-price-target-of-8
HC Wainwright & Co. Assumes Akebia Therape...
06/04/2025 11:20:49

HC Wainwright & Co. analyst Matthew Caufield assumes Akebia Therapeutics (NASDAQ:AKBA) with a Buy rating and announces P...

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
05/08/2025 12:07:05

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION